Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 26, 2020; 8(18): 3978-3987
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.3978
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.3978
Typical imaging features | Immunohistochemical staining markers | Molecular biology | |
HEHE | Target sign, lollipop sign, capsular retraction | CD31, CD34, CD10, vimentin, Factor VIII antigen | Fusion gene: WWTR1-CAMTA1, YAP1-TFE3 |
Angiosarcoma | Heterogeneous centripetal enhancement | CD31, CD34, Factor VIII antigen | HRAS, KRAS, NRAS and PTPRB mutation |
HH | Posterior shadowing and centripetal filling | - | - |
Cholangio carcinoma | Cholangiectasis, capsular retraction | Pan-cytokeratin | - |
Hepatocellular carcinoma | Hyperechoic enhancement in the arterial phase and hypoechoic enhancement in the portal and delayed phases | HepPar-1; Pan-cytokeratin | - |
Metastatic carcinoma | Bull's-eye sign | Pan-cytokeratin | - |
- Citation: Kou K, Chen YG, Zhou JP, Sun XD, Sun DW, Li SX, Lv GY. Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World J Clin Cases 2020; 8(18): 3978-3987
- URL: https://www.wjgnet.com/2307-8960/full/v8/i18/3978.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i18.3978